Figure S7 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
Abstract
Changes in CD8+ T cell and CD4+ (CD3+ CD8-) T cell responses in CT26/HAS tumours.
Fields of Study & Subjects
Proteoglycans and glycosaminoglycans research
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Publication details
- Publication date
- 4 March 2026
- Language
- EN